Valeritas Presents Data Demonstrating V-Go  ® Wearable Insulin Delivery Device ...

BRIDGEWATER, N.J., Feb. 15, 2018 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today it presented positive findings from its MOTIV4CONTROL study as a poster at The 11th International Conference on Advanced Technologies&...This story is related to the following:Medical Devices
Source: Industrial Newsroom - Health, Medical and Dental Supplies - Category: Medical Devices Source Type: news

Related Links:

Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - Category: Endocrinology Tags: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Source Type: research
Conclusions/interpretationFollowing an episode of severe hypoglycaemia managed by EMS, one-fifth of participants required hospital admission, more likely in those with advancing age, increasing comorbidities and injury and one-tenth required EMS again for severe hypoglycaemia in a 3  month period, more likely in those with a greater number of antecedent episodes and lower HbA1c. Knowledge of these factors associated with admission and recurrence provides an opportunity for development of targeted strategies aimed at prevention of severe hypoglycaemia in those most vulnerable.
Source: Diabetologia - Category: Endocrinology Source Type: research
Publication date: Available online 13 July 2019Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Nadia Hamjane, Fatiha Benyahya, Mohcine Bennani Mechita, Naima Ghailani Nourouti, Amina BarakatAbstractAimThe aim of this work was to study overweight and obesity and their associated complications according to obesity indicators in a population of Tangier.MethodsA total of 480 overweight and obese patients were included in this study, referred to hospital Duc Tovar of Tangier during a period of 12 months. The collection of data has been done through a questionnaire which included anthropometric...
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
ConclusionsAll 8 characteristics were shown to significantly influence choice, with cost and life expectancy carrying the most weight and serious and minor side effects carrying the least weight.RésuméObjectifsEstimer la force des préférences, l'importance relative et les compromis que les patients atteints du diabète de type 2 font entre les caractéristiques des antihyperglycémiants.MéthodesNous avons mené une expérimentation de choix discrets auprès d'un échantillon de Canadiens atteints du diabète de type 2. Les répond...
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
TYPE 2 diabetes is a condition which causes a person ’s blood glucose levels to become too high, and severe health problems can follow. Certain foods have been found to lower blood sugar and keep it in check, including a superfood native to Central America.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Publication date: Available online 13 July 2019Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Naser Parizad, Vajiheh Baghi, Elnaz Baghban Karimi, Reza Ghanei GheshlaghAbstractOsteoporosis is the most common metabolic bone disorder that is common in postmenopausal women with type 2 diabetes. Different studies have reported different prevalence of osteoporosis. This systematic review and meta-analysis was conducted to estimate the pooled prevalence of osteoporosis in Iranian postmenopausal women with type 2 diabetes. Search for eligible articles was performed using the keywords of osteopor...
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
ConclusionsThe mean MPV was statistically significantly higher in the uncontrolled DM group and there was a statistically significant positive correlation between MPV and albuminuria.
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
Publication date: Available online 12 July 2019Source: Prostaglandins, Leukotrienes and Essential Fatty AcidsAuthor(s): Kristina Starčević, Petra Roškarić, Marcela Šperanda, Mislav Đidara, Andrea Gudan Kurilj, Maja Maurić, Tomislav MašekABSTRACTWe studied the influence of dietary n6/n3 ratio and docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids supplementation on fatty acid profile, lipid peroxidation and NFκ/p50 expression in diabetes type 2. Treatments consisted of three dietary n6/n3 ratios: 6 (Control), 50 (high n6) and 1 (DHA and EPA supplemented). Half of the rats in each of the d...
Source: Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) - Category: Lipidology Source Type: research
Photo credit Huber Chaland Dear Carol: My dad has been Mom’s caregiver since her stroke ten years ago. Dad’s 79 and healthy except for Type 2 diabetes. I visit my parents every few days to help them out so I set up both of their medications for the week but Dad often leaves the diabetes medication in the pillbox. When I ask him why he says that the medication makes him feel dizzy and sluggish so he hates taking it. I remind him of the possible complications of diabetes but he brushes me off because he’s of normal weight and used to be physically active. That makes no sense since he has diabetes no ma...
Source: Minding Our Elders - Category: Geriatrics Authors: Source Type: blogs
CONCLUSIONS: Prevalence of diabetes and its risk factors were high among Samoans in Sydney with a high proportion with undiagnosed diabetes. SO WHAT?: These findings highlight the need to prioritise the delivery of culturally appropriate interventions tailored to the needs of the Samoan community. The high level of healthy lifestyle contemplation suggests that the community would be receptive to such interventions. This article is protected by copyright. All rights reserved. PMID: 31295377 [PubMed - as supplied by publisher]
Source: Health Promotion Journal of Australia - Category: International Medicine & Public Health Tags: Health Promot J Austr Source Type: research
More News: Conferences | Diabetes | Diabetes Type 2 | Endocrinology | Insulin | Medical Devices | Study